Meredith Corporation
MDP · NYSE
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.60 | -0.52 | -0.18 | 0.01 |
| FCF Yield | 0.67% | 1.27% | 2.48% | 9.82% |
| EV / EBITDA | 73.62 | 63.49 | 28.56 | 16.11 |
| Quality | ||||
| ROIC | 1.01% | 2.75% | 2.44% | 3.64% |
| Gross Margin | 62.40% | 63.13% | 62.05% | 70.44% |
| Cash Conversion Ratio | 1.71 | 1.66 | 0.96 | 1.23 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.48% | -1.97% | -2.96% | -1.55% |
| Free Cash Flow Growth | -32.62% | -25.04% | -60.81% | 150.43% |
| Safety | ||||
| Net Debt / EBITDA | 26.73 | 26.99 | 14.86 | 10.24 |
| Interest Coverage | 1.98 | 3.76 | 2.95 | 5.86 |
| Efficiency | ||||
| Inventory Turnover | 8.97 | 9.03 | 8.73 | 7.88 |
| Cash Conversion Cycle | 7.79 | 9.85 | 25.62 | 23.54 |